{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:51:46Z","timestamp":1761630706001},"reference-count":22,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"published-print":{"date-parts":[[2015,5,4]]},"DOI":"10.1586\/14737167.2015.995171","type":"journal-article","created":{"date-parts":[[2014,12,13]],"date-time":"2014-12-13T11:34:56Z","timestamp":1418470496000},"page":"539-543","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Cost\u2013effectiveness analysis of 5-fluorouracil 0.5%\/salicylic acid 10% in the treatment of actinic keratosis in Spain"],"prefix":"10.1586","volume":"15","author":[{"given":"Diana","family":"Nieves","sequence":"first","affiliation":[{"name":"1\rOblikue Consulting, C\/Josep Irla i Bosch, 5-7, 1a planta 08034, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Puig-Peir\u00f3","sequence":"additional","affiliation":[{"name":"2\rCentre for Research in Health and Economics-Pompeu Fabra University (CRES-UPF), Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Ferr\u00e1ndiz","sequence":"additional","affiliation":[{"name":"3\rDepartment of Dermatology, Germans Trias i Pujol University Hospital, Badalona, Autonomous University of Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Josep","family":"Plazas","sequence":"additional","affiliation":[{"name":"4\rMedical Department of Spain, Almirall S.A., Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Brosa","sequence":"additional","affiliation":[{"name":"1\rOblikue Consulting, C\/Josep Irla i Bosch, 5-7, 1a planta 08034, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,12,13]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2007.00339.x"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07692.x"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1159\/000112925"},{"key":"cit0004","first-page":"247","volume":"13","author":"Massa A","year":"2000","journal-title":"Acta Med Port"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03541.x"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.6.722"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.10.001"},{"key":"cit0008","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ad.2013.11.013","volume":"105","author":"Ferr\u00e1ndiz C","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2012.716039"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.1.66"},{"key":"cit0011","unstructured":"General Spanish Council of Pharmacist. Madrid. Spain, 2014. Available from: www.portalfarma.com [Last accessed 1 March 2014]"},{"key":"cit0012","unstructured":"Dirschka T , \nDominicus R , \nLars K , et al. Long term efficacy and recurrence of topical 0.5% 5-fluorouracil with 10% salicylic acid for actinic keratosis compared to cryotherapy a prospective, active controlled, randomized, exploratory study [Poster]. In: 6th World Meeting of Interdisciplinary Melanoma\/Skin Cancer Centres and 8th EADO Congress. Barcelona. Spain, 2012. Available from: www.eado.org\/activities\/eado-congress\/8 [Last accessed 1 March 2014]"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10387.x"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.2165\/11538670-000000000-00000"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.119649"},{"key":"cit0016","unstructured":"Spanish Health Costs Database eSalud. Oblikue Consulting S.L. Barcelona. Spain, 2014. Available at www.oblikue.com [Last accessed 7 july 2014]"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2012.1707"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08271.x"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1177\/120347540200600301"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24284"},{"key":"cit0021","first-page":"573","volume":"145","author":"Colombo GL","year":"2010","journal-title":"G Ital Dermatol Venereol"},{"key":"cit0022","unstructured":"Fluorouracil 0.5%\/ salicylic acid 10% cutaneous solution (Actikerall\u00ae). SMC No. (728\/11). Scottish Medicines Consortium (SMC). 2011. Available from: http:\/\/www.scottishmedicines.org.uk\/files\/advice\/fluorouracil_and_salicylic_acid_Actikerall_FINAL_September_2011_for_website.pdf [Last accessed 1 March 2014]"}],"container-title":["Expert Review of Pharmacoeconomics & Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14737167.2015.995171","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T13:15:55Z","timestamp":1694524555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14737167.2015.995171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,13]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5,4]]}},"alternative-id":["10.1586\/14737167.2015.995171"],"URL":"https:\/\/doi.org\/10.1586\/14737167.2015.995171","relation":{},"ISSN":["1473-7167","1744-8379"],"issn-type":[{"value":"1473-7167","type":"print"},{"value":"1744-8379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-05-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}